{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:57:45Z","timestamp":1792756665868,"version":"4.5.0"},"reference-count":66,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Compared with infections caused by other bacterial pathogens, urinary tract infections (UTIs) caused by Proteae are often more severe and associated with a higher rate of recurrence, sequelae, and pyelonephritis. The aim of this retrospective study was to assess and compare the prevalence of UTIs caused by different species of the Proteae tribe (namely Proteus, Morganella and Providencia species) and the antibiotic resistance levels isolated from inpatients and outpatients in a primary- and tertiary-care teaching hospital in the Southern Great Plain of Hungary, during a 10-year study period. To evaluate the resistance trends of isolated strains, amoxicillin\/clavulanic acid, ceftriaxone, meropenem, ertapenem, gentamicin, ciprofloxacin, and fosfomycin were chosen as indicator antibiotics, based on local antibiotic utilization data. Members of Proteae were more frequently isolated in the case of inpatients (7.20 \u00b1 1.74% vs. 5.00 \u00b1 0.88%; p = 0.0031), P. mirabilis was the most frequently isolated member of the group. The ratio of resistant strains to sulfamethoxazole\/trimethoprim, ciprofloxacin, ceftriaxone, and fosfomycin was significantly higher in the inpatient group. In the case of amoxicillin\/clavulanic acid, ceftriaxone, ciprofloxacin, and sulfamethoxazole\/trimethoprim, the ratio of resistant isolates was markedly higher between 2013\u20132017 (p &lt; 0.01). Resistance developments of Proteae, coupled with their intrinsic non-susceptibility to several antibiotics (tetracyclines, colistin, nitrofurantoin) severely limits the number of therapeutic alternatives, especially for outpatients.<\/jats:p>","DOI":"10.3390\/antibiotics8030091","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T11:28:28Z","timestamp":1562844508000},"page":"91","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Comparative Epidemiology and Resistance Trends of Proteae in Urinary Tract Infections of Inpatients and Outpatients: A 10-Year Retrospective Study"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1270-0365","authenticated-orcid":false,"given":"M\u00e1ri\u00f3","family":"Gajd\u00e1cs","sequence":"first","affiliation":[{"name":"Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, 6720 Szeged, E\u00f6tv\u00f6s utca 6., Hungary"},{"name":"Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged, 6725 Szeged, Semmelweis utca 6., Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Urb\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Public Health, Faculty of Medicine, University of Szeged, 6720 Szeged, D\u00f3m t\u00e9r 10., Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious diseases society of America and the European society for microbiology and infectious diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/antibiotics3030341","article-title":"Uncomplicated urinary tract infections and antibiotic resistance-epidemiological and mechanistic aspects","volume":"3","author":"Wiedemann","year":"2014","journal-title":"Antibiotics"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Walker","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the infectious diseases society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10096-016-2673-1","article-title":"Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland","volume":"35","author":"Stefaniuk","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"Achkar","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00431-016-2763-1","article-title":"Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children","volume":"175","author":"Calzi","year":"2016","journal-title":"Eur. J. Pediatr."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs, M. (2019). The concept of an ideal antibiotic: Implications for drug design. Molecules, 24.","DOI":"10.3390\/molecules24050892"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Spengler, G., Kincses, A., Gajdacs, M., and Amaral, L. (2017). New roads leading to old destinations: Efflux pumps as targets to reverse multidrug resistance in bacteria. Molecules, 22.","DOI":"10.3390\/molecules22030468"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Codjoe, F.S., and Donkor, E.S. (2018). Carbapenem resistance: A review. Med. Sci., 6.","DOI":"10.3390\/medsci6010001"},{"key":"ref_11","first-page":"625170","article-title":"ESBLs: A clear and present danger?","volume":"2012","author":"Dhillon","year":"2012","journal-title":"Crit. Care Res. Pract."},{"key":"ref_12","first-page":"31","article-title":"[Extra deaths due to pandrug resistant bacteria: A survey of the literature]","volume":"60","year":"2019","journal-title":"Eg\u00e9szs\u00e9gfejleszt\u00e9s"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/CMR.13.4.534","article-title":"Classification, identification, and clinical significance of Proteus, Providencia, and Morganella","volume":"13","author":"Brenner","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, K.-H., and Stackebrandt, E. (2006). The genera Proteus, Providencia, and Morganella. The Prokaryotes: Volume 6: Proteobacteria: Gamma Subclass, Springer.","DOI":"10.1007\/0-387-30746-X"},{"key":"ref_15","unstructured":"(2019, May 14). Taxonomy of the family Morganellaceae Adeolu et al. 2016. Available online: https:\/\/www.namesforlife.com\/10.1601\/tx.29308."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1099\/ijsem.0.001485","article-title":"Genome-based phylogeny and taxonomy of the \u201cEnterobacteriales\u201d: Proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov","volume":"66","author":"Adeolu","year":"2016","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/ajcp\/70.6.905","article-title":"Identification of Proteus morganii and distinction from other Proteus species","volume":"70","author":"Braunstein","year":"1978","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/JCM.37.9.2840-2847.1999","article-title":"Molecular characterization of the Genera Proteus, Morganella, and Providencia by Ribotyping","volume":"37","author":"Pignato","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-1097(97)00006-2","article-title":"Cloning and sequencing of the gene encoding the AmpC beta-lactamase of Morganella morganii","volume":"148","author":"Barnaud","year":"1997","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000239146","article-title":"In vitro experiments on catheter-related infections due to gram-negative rods","volume":"39","author":"Penner","year":"1993","journal-title":"Chemotherapy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7624857","DOI":"10.1155\/2018\/7624857","article-title":"Catheter-associated urinary tract infection and obstinate biofilm producers","volume":"2018","author":"Maharjan","year":"2018","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2986742","DOI":"10.1155\/2018\/2986742","article-title":"Review of catheter-associated urinary tract infections and in vitro urinary tract models","volume":"2018","author":"Cortese","year":"2018","journal-title":"J. Healthc. Eng."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1128\/CMR.00019-07","article-title":"Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis","volume":"21","author":"Jacobsen","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/1120009X.2017.1380395","article-title":"Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: A review","volume":"29","author":"Mazzariol","year":"2017","journal-title":"J. Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3390\/ph6111335","article-title":"A review of ten years of the study for monitoring antimicrobial resistance trends (SMART) from 2002 to 2011","volume":"6","author":"Morrissey","year":"2013","journal-title":"Pharmaceuticals"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009\u20132012","volume":"43","author":"Sader","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ponce-de-Leon, A., Rodr\u00edguez-Noriega, E., Morf\u00edn-Otero, R., Cornejo-Ju\u00e1rez, D.P., Tinoco, J.C., Mart\u00ednez-Gamboa, A., Gaona-Tapia, C.J., Guerrero-Almeida, M.L., Martin-Onra\u00ebt, A., and Vallejo Cervantes, J.L. (2018). Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the study for monitoring antimicrobial resistance trends (SMART). PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198621"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1469-0691.2007.01715.x","article-title":"Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region","volume":"13","author":"Laupland","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","article-title":"Extended-spectrum \u03b2-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: An increasing challenge for antimicrobial therapy","volume":"39","author":"Meier","year":"2011","journal-title":"Infection"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0924-8579(00)00325-3","article-title":"Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam\/beta-lactamase inhibitor combinations","volume":"17","author":"Luzzaro","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1099\/jmm.0.000498","article-title":"Spectrum and antibiotic resistance of uropathogens between 2004 and 2015 in a tertiary care hospital in Hungary","volume":"66","author":"Magyar","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.idc.2013.10.003","article-title":"Diagnosis and management of urinary tract infection in the emergency department and outpatient settings","volume":"28","author":"Takhar","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/1120009X.2017.1418646","article-title":"Analysis of the spectrum and antibiotic resistance of uropathogens in outpatients a. tertiary hospital","volume":"30","author":"Yang","year":"2018","journal-title":"J. Chemother."},{"key":"ref_34","first-page":"249","article-title":"[The opinions of community pharmacists related to antibiotic use and resistance] (article in Hungarian)","volume":"88","author":"Paulik","year":"2018","journal-title":"Acta Pharm. Hung."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/0036554021000027015","article-title":"Bacteraemia due to tribe Proteeae: A review of 132 cases during a decade (1991\u20132000)","volume":"35","author":"Kim","year":"2003","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/antibiotics3020174","article-title":"Antimicrobial stewardship and urinary tract infections","volume":"3","author":"Abbo","year":"2014","journal-title":"Antibiotics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/antibiotics3010039","article-title":"Role of old antibiotics in the era of antibiotic resistance. Highlighted nitrofurantoin for the treatment of lower urinary tract infections","volume":"3","year":"2014","journal-title":"Antibiotics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s15010-009-8460-5","article-title":"Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes","volume":"38","author":"Riesenberg","year":"2010","journal-title":"Infection"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yeika, E.V., Foryoung, J.B., Efie, D.T., Nkwetateba, E.A., Tolefac, P.N., and Ngowe, M.N. (2018). Multidrug resistant Proteus mirabilis and Escherichia coli causing fulminant necrotising fasciitis: A case report. BMC Res. Notes, 11.","DOI":"10.1186\/s13104-018-3413-7"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wagenlehner, F., Tandogdu, Z., Bartoletti, R., Cai, T., Cek, M., Kulchavenya, E., K\u00f6ves, B., Naber, K., Perepanova, T., and Tenke, P. (2016). The global prevalence of infections in urology study: A long-term, worldwide surveillance study on urological infections. Pathogens, 5.","DOI":"10.3390\/pathogens5010010"},{"key":"ref_41","first-page":"209","article-title":"Epidemiology of candiduria and Candida urinary tract infections in inpatients and outpatients: Results from a 10-year retrospective survey","volume":"72","year":"2019","journal-title":"Cent. Eur. J. Urol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs, M., and Urb\u00e1n, E. (2019). Resistance trends and epidemiology of citrobacter-enterobacter-serratia in urinary tract infections of inpatients and outpatients (RECESUTI): A 10-year survey. Medicina, 55.","DOI":"10.3390\/medicina55060285"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"ofy297","DOI":"10.1093\/ofid\/ofy297","article-title":"Antimicrobial susceptibility trends observed in urinary pathogens obtained from New York State","volume":"5","author":"Rank","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs, M., Spengler, G., and Urb\u00e1n, E. (2017). Identification and antimicrobial susceptibility testing of anaerobic bacteria: Rubik\u2019s cube of clinical microbiology?. Antibiotics, 6.","DOI":"10.3390\/antibiotics6040025"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3947\/ic.2018.50.1.67","article-title":"Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections","volume":"50","author":"Kang","year":"2018","journal-title":"Infect. Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1128\/JCM.01077-15","article-title":"Challenges in preparation of cumulative antibiogram reports for community hospitals","volume":"53","author":"Moehring","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jac\/dkx441","article-title":"Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model","volume":"73","author":"Abbott","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cmi.2017.12.026","article-title":"Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: A multinational prospective cohort study","volume":"24","author":"Stewardson","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cmi.2018.03.038","article-title":"Fluoroquinolones for urinary tract infection and within-household spread of resistant Enterobacteriaceae: The smoking gun","volume":"24","author":"Trautner","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13756-018-0368-3","article-title":"Characteristics of the antibiotic regimen that affect antimicrobial resistance in urinary pathogens","volume":"7","author":"Catry","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"P22","DOI":"10.1186\/2047-2994-2-S1-P22","article-title":"Antibiograms of consecutive urinary tract samples in elderly","volume":"2","author":"Latour","year":"2013","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/antibiotics3020163","article-title":"Adult and pediatric intra-institutional trends of ciprofloxacin susceptibility in E. coli positive urinary cultures","volume":"3","author":"Owumi","year":"2014","journal-title":"Antibiotics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"vi71","DOI":"10.1093\/jac\/dkr459","article-title":"European surveillance of antimicrobial consumption (ESAC): Quality appraisal of antibiotic use in Europe","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1244","article-title":"Antibiotic use in ambulatory care in Europe (ESAC data 1997\u20132002): Trends, regional differences and seasonal fluctuations","volume":"16","author":"Elseviers","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0463.2009.02563.x","article-title":"Beta-lactam antibiotics: From antibiosis to resistance and bacteriology","volume":"118","author":"Kong","year":"2010","journal-title":"APMIS"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003495-200363040-00002","article-title":"Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: Considerations for diagnosis, prevention and drug treatment","volume":"63","author":"Rupp","year":"2003","journal-title":"Drugs"},{"key":"ref_57","first-page":"110","article-title":"CTX-M enzymes: Origin and diffusion","volume":"3","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/jac\/36.2.335","article-title":"Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins","volume":"36","author":"Neuwirth","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_59","unstructured":"National Health Insurance Fund of Hungary (2017). Hospital Bed Count and Patient Turnover Report 2017, National Health Insurance Fund of Hungary."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs, M., and Urb\u00e1n, E. (2019). Epidemiological trends and resistance associated with Stenotrophomonas maltophilia bacteremia: A 10-year retrospective cohort study in a tertiary-care hospital in Hungary. Diseases, 7.","DOI":"10.3390\/diseases7020041"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mimet.2017.11.021","article-title":"Combination of MALDI-TOF MS and PBP2\u2019 latex agglutination assay for rapid MRSA detection","volume":"144","year":"2018","journal-title":"J. Microbiol. Methods"},{"key":"ref_62","first-page":"1839","article-title":"[Antibiotic use in the Hungarian hospitals in the last two decades (1996\u20132015)]","volume":"157","author":"Matuz","year":"2016","journal-title":"ORVOSI HETILAP"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1556\/OH.2014.29804","article-title":"[Treatment practice of acute cystitis on the basis of national prescription data]","volume":"155","author":"Matuz","year":"2014","journal-title":"ORVOSI HETILAP"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1556\/OH.2013.29632","article-title":"[Evaluation of ambulatory antibiotic use in Hungary using drug-specific quality indicators]","volume":"154","author":"Matuz","year":"2013","journal-title":"ORVOSI HETILAP"},{"key":"ref_65","first-page":"26","article-title":"[The attitude of community pharmacists towards their widening roles in the prevention and treatment of infectious diseases in the southeast region of Hungary] (article in Hungarian)","volume":"63","author":"Paulik","year":"2019","journal-title":"Gy\u00f3gyszer\u00e9szet"},{"key":"ref_66","unstructured":"Gajd\u00e1cs, M., \u00c1br\u00f3k, M., L\u00e1z\u00e1r, A., and Buri\u00e1n, K. (2019). [Susceptibility patterns of extended-spectrum beta-lactamase-producing (ESBL) urinary pathogens: Single-center experience.] (article in Hungarian). Gy\u00f3gyszer\u00e9szet, in press."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/8\/3\/91\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:04:31Z","timestamp":1760187871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/8\/3\/91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["antibiotics8030091"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics8030091","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]}}}